What is the category of Nippon India Pharma Fund - Direct Plan - Growth Plan ?
The category of Nippon India Pharma Fund - Direct Plan - Growth Plan is Equity - Sector - Healthcare
What is the current NAV of Nippon India Pharma Fund - Direct Plan - Growth Plan ?
The current NAV of Nippon India Pharma Fund - Direct Plan - Growth Plan
(as on Mar 7, 2025) is
₹ 519.52
How safe is Nippon India Pharma Fund - Direct Plan - Growth Plan?
The risk level of Nippon India Pharma Fund - Direct Plan - Growth Plan is Very High .
What are short term returns given by Nippon India Pharma Fund - Direct Plan - Growth Plan?
The return given by Nippon India Pharma Fund - Direct Plan - Growth Plan in
1 month is -5.78%,
3 months is -9.26%,
6 months is -9.65%,
and 1 year is 10.23%.
What are the long term returns given by Nippon India Pharma Fund - Direct Plan - Growth Plan?
The return given by Nippon India Pharma Fund - Direct Plan - Growth Plan in
3 years is 20.99% and
5 years is 25.02%.
What is the expense ratio of Nippon India Pharma Fund - Direct Plan - Growth Plan?
The expense ratio of Nippon India Pharma Fund - Direct Plan - Growth Plan is
1.03 %
What is the AUM of Nippon India Pharma Fund - Direct Plan - Growth Plan
The assets under Management (AUM) of Nippon India Pharma Fund - Direct Plan - Growth Plan is
Rs 8,160.74 crores.
What is the minimum investment in Nippon India Pharma Fund - Direct Plan - Growth Plan?
The minimum Lumpsum investment in Nippon India Pharma Fund - Direct Plan - Growth Plan is
₹5000
and the minimum SIP investment in Nippon India Pharma Fund - Direct Plan - Growth Plan is ₹100
What is the asset allocation of Nippon India Pharma Fund - Direct Plan - Growth Plan?
The Nippon India Pharma Fund - Direct Plan - Growth Plan has an exposure of
98.64%
in Equity,
and
1.36%
in Cash
& Money Market Securities